Cargando…
Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity
Tylophorine-based compounds exert broad spectral, potent inhibition of coronaviruses. NF-κB activation is a common pro-inflammatory response of host cells to viral infection. The aims of this study were to (i) find an effective combination treatment for coronaviral infections through targeting of th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481340/ https://www.ncbi.nlm.nih.gov/pubmed/28642467 http://dx.doi.org/10.1038/s41598-017-04203-9 |
_version_ | 1783245376497647616 |
---|---|
author | Yang, Cheng-Wei Lee, Yue-Zhi Hsu, Hsing-Yu Shih, Chuan Chao, Yu-Sheng Chang, Hwan-You Lee, Shiow-Ju |
author_facet | Yang, Cheng-Wei Lee, Yue-Zhi Hsu, Hsing-Yu Shih, Chuan Chao, Yu-Sheng Chang, Hwan-You Lee, Shiow-Ju |
author_sort | Yang, Cheng-Wei |
collection | PubMed |
description | Tylophorine-based compounds exert broad spectral, potent inhibition of coronaviruses. NF-κB activation is a common pro-inflammatory response of host cells to viral infection. The aims of this study were to (i) find an effective combination treatment for coronaviral infections through targeting of the virus per se and cellular NF-κB activity; and (ii) to study the underling mechanisms. We found that tylophorine-based compounds target the TGEV viral RNA and effectively inhibit TGEV replication. NF-κB inhibition also leads to anti-TGEV replication. NF-κB activation induced by TGEV infection was found to be associated with two convergent pathways, IKK-2_IκBα/p65 and JAK2 mediated p65 phosphorylation, in swine testicular cells. JAK2 inhibition either by CYT387 (a JAK family inhibitor) or by silencing JAK2-expression revealed a dominant JAK2 mediated p65 phosphorylation pathway for NF-κB activation and resulted in NF-κB inhibition, which overrode the IκBα regulation via the IKK-2. Finally, tylophorine-based compounds work cooperatively with CYT387 to impart comprehensive anti-TGEV activities. The combination treatment, wherein a tylophorine compound targets TGEV and a JAK2 inhibitor blocks the alternative dominant NF-κB activation mediated by JAK2, is more effective and comprehensive than either one alone and constitutes a feasible approach for the treatment of SARS-CoV or MERS-CoV. |
format | Online Article Text |
id | pubmed-5481340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-54813402017-06-26 Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity Yang, Cheng-Wei Lee, Yue-Zhi Hsu, Hsing-Yu Shih, Chuan Chao, Yu-Sheng Chang, Hwan-You Lee, Shiow-Ju Sci Rep Article Tylophorine-based compounds exert broad spectral, potent inhibition of coronaviruses. NF-κB activation is a common pro-inflammatory response of host cells to viral infection. The aims of this study were to (i) find an effective combination treatment for coronaviral infections through targeting of the virus per se and cellular NF-κB activity; and (ii) to study the underling mechanisms. We found that tylophorine-based compounds target the TGEV viral RNA and effectively inhibit TGEV replication. NF-κB inhibition also leads to anti-TGEV replication. NF-κB activation induced by TGEV infection was found to be associated with two convergent pathways, IKK-2_IκBα/p65 and JAK2 mediated p65 phosphorylation, in swine testicular cells. JAK2 inhibition either by CYT387 (a JAK family inhibitor) or by silencing JAK2-expression revealed a dominant JAK2 mediated p65 phosphorylation pathway for NF-κB activation and resulted in NF-κB inhibition, which overrode the IκBα regulation via the IKK-2. Finally, tylophorine-based compounds work cooperatively with CYT387 to impart comprehensive anti-TGEV activities. The combination treatment, wherein a tylophorine compound targets TGEV and a JAK2 inhibitor blocks the alternative dominant NF-κB activation mediated by JAK2, is more effective and comprehensive than either one alone and constitutes a feasible approach for the treatment of SARS-CoV or MERS-CoV. Nature Publishing Group UK 2017-06-22 /pmc/articles/PMC5481340/ /pubmed/28642467 http://dx.doi.org/10.1038/s41598-017-04203-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Yang, Cheng-Wei Lee, Yue-Zhi Hsu, Hsing-Yu Shih, Chuan Chao, Yu-Sheng Chang, Hwan-You Lee, Shiow-Ju Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity |
title | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity |
title_full | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity |
title_fullStr | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity |
title_full_unstemmed | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity |
title_short | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity |
title_sort | targeting coronaviral replication and cellular jak2 mediated dominant nf-κb activation for comprehensive and ultimate inhibition of coronaviral activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481340/ https://www.ncbi.nlm.nih.gov/pubmed/28642467 http://dx.doi.org/10.1038/s41598-017-04203-9 |
work_keys_str_mv | AT yangchengwei targetingcoronaviralreplicationandcellularjak2mediateddominantnfkbactivationforcomprehensiveandultimateinhibitionofcoronaviralactivity AT leeyuezhi targetingcoronaviralreplicationandcellularjak2mediateddominantnfkbactivationforcomprehensiveandultimateinhibitionofcoronaviralactivity AT hsuhsingyu targetingcoronaviralreplicationandcellularjak2mediateddominantnfkbactivationforcomprehensiveandultimateinhibitionofcoronaviralactivity AT shihchuan targetingcoronaviralreplicationandcellularjak2mediateddominantnfkbactivationforcomprehensiveandultimateinhibitionofcoronaviralactivity AT chaoyusheng targetingcoronaviralreplicationandcellularjak2mediateddominantnfkbactivationforcomprehensiveandultimateinhibitionofcoronaviralactivity AT changhwanyou targetingcoronaviralreplicationandcellularjak2mediateddominantnfkbactivationforcomprehensiveandultimateinhibitionofcoronaviralactivity AT leeshiowju targetingcoronaviralreplicationandcellularjak2mediateddominantnfkbactivationforcomprehensiveandultimateinhibitionofcoronaviralactivity |